Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I. Kakegawa S, et al. Among authors: takeyoshi i. Cancer. 2011 Sep 15;117(18):4257-66. doi: 10.1002/cncr.26010. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387273 Free article.
Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
Araki T, Shimizu K, Nakamura K, Nakamura T, Mitani Y, Obayashi K, Fujita Y, Kakegawa S, Miyamae Y, Kaira K, Ishidao T, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K. Araki T, et al. Among authors: takeyoshi i. J Mol Diagn. 2010 Jan;12(1):118-24. doi: 10.2353/jmoldx.2010.090081. Epub 2009 Dec 10. J Mol Diagn. 2010. PMID: 20007840 Free PMC article.
Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.
Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I. Miyamae Y, et al. Among authors: takeyoshi i. J Mol Diagn. 2010 Mar;12(2):257-64. doi: 10.2353/jmoldx.2010.090105. Epub 2010 Jan 21. J Mol Diagn. 2010. PMID: 20093389 Free PMC article.
Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma.
Araki T, Shimizu K, Nakamura T, Baba M, Kawai Y, Nakamura K, Mitani Y, Obayashi K, Aomori T, Fujita Y, Miyamae Y, Kakegawa S, Kaira K, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K. Araki T, et al. Among authors: takeyoshi i. Oncol Rep. 2011 Nov;26(5):1213-9. doi: 10.3892/or.2011.1391. Epub 2011 Jul 15. Oncol Rep. 2011. PMID: 21769434
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.
Ohtaki Y, Shimizu K, Kakegawa S, Nagashima T, Nakano T, Atsumi J, Enokida Y, Igai H, Ibe T, Sugano M, Kamiyoshihara M, Kawashima O, Kaira K, Sunaga N, Takeyoshi I. Ohtaki Y, et al. Among authors: takeyoshi i. Mol Clin Oncol. 2014 Mar;2(2):187-196. doi: 10.3892/mco.2013.237. Epub 2013 Dec 31. Mol Clin Oncol. 2014. PMID: 24649331 Free PMC article.
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
Enokida Y, Shimizu K, Atsumi J, Kakegawa S, Takase Y, Kaira K, Yashima H, Araki T, Nakazawa S, Ohtaki Y, Nagashima T, Alexander L, Usui K, Ishikawa T, Hayashizaki Y, Takeyoshi I. Enokida Y, et al. Among authors: takeyoshi i. Cancer Med. 2016 Aug;5(8):1791-801. doi: 10.1002/cam4.750. Epub 2016 May 26. Cancer Med. 2016. PMID: 27228500 Free PMC article.
Primary thymic mucosa-associated lymphoid tissue lymphoma: diagnostic tips.
Shimizu K, Yoshida J, Kakegawa S, Astumi J, Kaira K, Oshima K, Miyanaga T, Kamiyoshihara M, Nagai K, Takeyoshi I. Shimizu K, et al. Among authors: takeyoshi i. J Thorac Oncol. 2010 Jan;5(1):117-21. doi: 10.1097/JTO.0b013e3181c07df8. J Thorac Oncol. 2010. PMID: 19884857 Free article.
318 results